Raymond James Financial
GSK icon

Raymond James Financial’s GSK GSK Stock Holding History

Raymond James Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.2M Buy
1,396,694
+25,117
+2% +$1.33M 0.02% 716
2026
Q1 		$75.7M Sell
1,371,577
-1,104,162
-45% -$59.8M 0.02% 630
2025
Q4 		$121M Sell
2,475,739
-316,886
-11% -$14.8M 0.04% 427
2025
Q3 		$121M Sell
2,792,625
-41,737
-1% -$1.63M 0.04% 434
2025
Q2 		$109M Buy
2,834,362
+1,259,319
+80% +$48.1M 0.04% 453
2025
Q1 		$61M Buy
1,575,043
+191,886
+14% +$7.02M 0.02% 626
2024
Q4 		$46.8M Buy
+1,383,157
New +$49.8M 0.02% 760

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Raymond James Financial's GSK Position: Q2 2026 in Review

Raymond James Financial increased its GSK (GSK) stake by 1.8% in Q2 2026, buying an estimated $1.33M and bringing the position to 1,396,694 shares worth $73.2M. The position accounts for 0.02% of the portfolio, ranked #716.

Raymond James Financial first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $121M in Q4 2025. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Raymond James Financial held 1,396,694 shares of GSK worth $73.2M as of Q2 2026.
  • Raymond James Financial bought 25,117 GSK shares in Q2 2026, an estimated $1.33M.
  • GSK made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #716 holding.
  • Raymond James Financial first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's GSK position peaked at $121M in Q4 2025.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.